Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 140

Similar articles for PubMed (Select 24443055)

1.

An expanded population of CD34+ cells from frozen banked umbilical cord blood demonstrate tissue repair mechanisms of mesenchymal stromal cells and circulating angiogenic cells in an ischemic hind limb model.

Whiteley J, Bielecki R, Li M, Chua S, Ward MR, Yamanaka N, Stewart DJ, Casper RF, Rogers IM.

Stem Cell Rev. 2014 Jun;10(3):338-50. doi: 10.1007/s12015-014-9496-1.

PMID:
24443055
2.

CD34 hybrid cells promote endothelial colony-forming cell bioactivity and therapeutic potential for ischemic diseases.

Lee JH, Lee SH, Yoo SY, Asahara T, Kwon SM.

Arterioscler Thromb Vasc Biol. 2013 Jul;33(7):1622-34. doi: 10.1161/ATVBAHA.112.301052. Epub 2013 May 2.

3.

Human adipose tissue-derived mesenchymal stem cells improve postnatal neovascularization in a mouse model of hindlimb ischemia.

Moon MH, Kim SY, Kim YJ, Kim SJ, Lee JB, Bae YC, Sung SM, Jung JS.

Cell Physiol Biochem. 2006;17(5-6):279-90. Epub 2006 Jun 20.

PMID:
16791003
4.

Efficient nonadhesive ex vivo expansion of early endothelial progenitor cells derived from CD34+ human cord blood fraction for effective therapeutic vascularization.

O E, Lee BH, Ahn HY, Shin JC, Kim HK, Kim M, Park IY, Park YG, Joe YA.

FASEB J. 2011 Jan;25(1):159-69. doi: 10.1096/fj.10-162040. Epub 2010 Sep 17.

5.

Endothelial progenitor cells derived from Wharton's jelly of the umbilical cord reduces ischemia-induced hind limb injury in diabetic mice by inducing HIF-1α/IL-8 expression.

Shen WC, Liang CJ, Wu VC, Wang SH, Young GH, Lai IR, Chien CL, Wang SM, Wu KD, Chen YL.

Stem Cells Dev. 2013 May 1;22(9):1408-18. doi: 10.1089/scd.2012.0445. Epub 2013 Feb 15.

6.

Direct comparison of umbilical cord blood versus bone marrow-derived endothelial precursor cells in mediating neovascularization in response to vascular ischemia.

Finney MR, Greco NJ, Haynesworth SE, Martin JM, Hedrick DP, Swan JZ, Winter DG, Kadereit S, Joseph ME, Fu P, Pompili VJ, Laughlin MJ.

Biol Blood Marrow Transplant. 2006 May;12(5):585-93.

7.

Co-culture of cord blood CD34(+) cells with human BM mesenchymal stromal cells enhances short-term engraftment of cord blood cells in NOD/SCID mice.

Fei XM, Wu YJ, Chang Z, Miao KR, Tang YH, Zhou XY, Wang LX, Pan QQ, Wang CY.

Cytotherapy. 2007;9(4):338-47.

PMID:
17573609
8.

[Human bone marrow stromal cells facilitate the cord blood CD34+ cells ex vivo expansion and short-term engraftment in NOD/SCID mice].

Fei XM, Wu YJ, Chang Z, Miao KR, Zhou XY, Pan QQ, Wang CY.

Zhonghua Xue Ye Xue Za Zhi. 2008 Feb;29(2):97-100. Chinese.

PMID:
18681309
10.

Myoendothelial differentiation of human umbilical cord blood-derived stem cells in ischemic limb tissues.

Pesce M, Orlandi A, Iachininoto MG, Straino S, Torella AR, Rizzuti V, Pompilio G, Bonanno G, Scambia G, Capogrossi MC.

Circ Res. 2003 Sep 5;93(5):e51-62. Epub 2003 Aug 14.

11.

[Mesenchymal stem cells from human cord blood promote engraftment of human umbilical cord blood-derived CD34+ cells in NOD/SCID mice].

Zhou DH, Huang SL, Huang K, Wu YF, Bao R, Wei J, Zhang XC, Li Y.

Zhonghua Xue Ye Xue Za Zhi. 2005 Dec;26(12):732-5. Chinese.

PMID:
16620577
12.

Umbilical cord blood-selected CD133(+) cells exhibit vasculogenic functionality in vitro and in vivo.

Finney MR, Fanning LR, Joseph ME, Goldberg JL, Greco NJ, Bhakta S, Winter DG, Forster M, Scheid PE, Sabe M, Pompili VJ, Laughlin MJ.

Cytotherapy. 2010;12(1):67-78. doi: 10.3109/14653240903300658.

PMID:
19878081
13.

Tumor necrosis factor-α-activated mesenchymal stem cells promote endothelial progenitor cell homing and angiogenesis.

Kwon YW, Heo SC, Jeong GO, Yoon JW, Mo WM, Lee MJ, Jang IH, Kwon SM, Lee JS, Kim JH.

Biochim Biophys Acta. 2013 Dec;1832(12):2136-44. doi: 10.1016/j.bbadis.2013.08.002. Epub 2013 Aug 16.

14.

Human adult vena saphena contains perivascular progenitor cells endowed with clonogenic and proangiogenic potential.

Campagnolo P, Cesselli D, Al Haj Zen A, Beltrami AP, Kränkel N, Katare R, Angelini G, Emanueli C, Madeddu P.

Circulation. 2010 Apr 20;121(15):1735-45. doi: 10.1161/CIRCULATIONAHA.109.899252. Epub 2010 Apr 5.

15.

Up-regulation of miR-210 by vascular endothelial growth factor in ex vivo expanded CD34+ cells enhances cell-mediated angiogenesis.

Alaiti MA, Ishikawa M, Masuda H, Simon DI, Jain MK, Asahara T, Costa MA.

J Cell Mol Med. 2012 Oct;16(10):2413-21. doi: 10.1111/j.1582-4934.2012.01557.x.

16.

Protective role of functionalized single walled carbon nanotubes enhance ex vivo expansion of hematopoietic stem and progenitor cells in human umbilical cord blood.

Bari S, Chu PP, Lim A, Fan X, Gay FP, Bunte RM, Lim TK, Li S, Chiu GN, Hwang WY.

Nanomedicine. 2013 Nov;9(8):1304-16. doi: 10.1016/j.nano.2013.05.009. Epub 2013 Jun 1.

PMID:
23732300
17.

Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice.

Noort WA, Kruisselbrink AB, in't Anker PS, Kruger M, van Bezooijen RL, de Paus RA, Heemskerk MH, Löwik CW, Falkenburg JH, Willemze R, Fibbe WE.

Exp Hematol. 2002 Aug;30(8):870-8.

PMID:
12160838
18.

Toll-like receptor 3 regulates cord blood-derived endothelial cell function in vitro and in vivo.

Grelier A, Cras A, Balitrand N, Delmau C, Lecourt S, Lepelletier Y, Riesterer H, Freida D, Lataillade JJ, Lebousse-Kerdiles MC, Cuccini W, Peffault de Latour R, Marolleau JP, Uzan G, Larghero J, Vanneaux V.

Angiogenesis. 2013 Oct;16(4):821-36. doi: 10.1007/s10456-013-9358-5. Epub 2013 Jun 8.

PMID:
23748743
19.

In vitro and in vivo evidence for the long-term multilineage (myeloid, B, NK, and T) reconstitution capacity of ex vivo expanded human CD34(+) cord blood cells.

Kobari L, Pflumio F, Giarratana M, Li X, Titeux M, Izac B, Leteurtre F, Coulombel L, Douay L.

Exp Hematol. 2000 Dec;28(12):1470-80.

PMID:
11146169
20.

Isolation and ex vivo expansion of human umbilical cord blood-derived CD34+ stem cells and their cotransplantation with or without mesenchymal stem cells.

Delalat B, Pourfathollah AA, Soleimani M, Mozdarani H, Ghaemi SR, Movassaghpour AA, Kaviani S.

Hematology. 2009 Jun;14(3):125-32. doi: 10.1179/102453309X402250.

PMID:
19490756
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk